Cara Therapeutics | CARA - DEBITO





DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 14.11B 1.93B 2022-12
Cipla INR 6.99B 857M 2026-09
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 3.02M 91K 2026-06
CSL USD 11.96B 219M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
J&J USD 49.04B 5.95B 2026-06
Neurocrine Biosciences USD 401.8M 4.4M 2026-06
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
RedHill Biopharma USD 214K 142K 2025-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12